William Dongfang Shi, Atom Bioscience CEO and founder
October 16, 2023 11:05 AM EDT
Financing
R&D

Atom Bio­science rais­es $83M in Se­ries D for URAT1 in­hibitor in chron­ic gout treat­ment

Katherine Lewin

News Reporter

Atom Bio­science has pulled in $83 mil­lion in Se­ries D fi­nanc­ing for its URAT1 in­hibitor for chron­ic gout, the com­pa­ny an­nounced …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
ENDPOINTS CAREERS

Director of IT, Security

Viridian Therapeutics

Waltham, MA, USA

TRENDING NOW

J&J trims pipeline, in­clud­ing two mid-stage neu­ro­science stud­ies

For­bion rais­es €2.1B for two new biotech funds af­ter se­ries of com­pa­ny ex­its

Pfiz­er part­ners with mol­e­c­u­lar glue start­up Tri­ana in $49M up­front deal

Mary­land biotech gets green light for stem cell-de­rived ther­a­py for di­a­betes, aim­ing to com­pete with Ver­tex

Ex­clu­sive: Biotech tools com­pa­ny rais­es $75M for pro­tein man­u­fac­tur­ing tech 

sponsored

Join the Gen­Script Biotech Glob­al Fo­rum: Un­lock­ing In­no­va­tions in Cell and Gene Ther­a­pies

A service from the Financial Times